- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02090010
Subclavian Vein catheterization_Seldinger Vs Modified Seldinger (MS)
Comparison of Two Needle Insertion Techniques on Success Rate and Complications During Subclavian Venous Catheterization: Seldinger vs. Modified Seldinger Technique
Seldinger technique is a minimally invasive technique in which the practitioner accesses the target vessel with a small bore needle, then dilates to the size required for the catheter. Contrarily, modified Seldinger technique(guiding sheath-over-the-needle technique) use needle that is covered with guiding sheath.
Both technique is widely used in central venous catheterization, however, few researches have been investigated to compare success rate or complications of both methods.
Study Overview
Status
Intervention / Treatment
Detailed Description
The major complications of central venous catheterization through subclavian vein, are unintended arterial puncture, pneumothorax, hemothorax, malposition of catheter etc,. We assume that using modified Seldinger technique (MST), guiding sheath is easily slid over the needle, providing stable route into the vessel lumen relatively.
We aimed to compare the Seldinger technique and modified Seldinger technique(MST) on success rate and complications during subclavian central venous catheterization in this prospective, randomized , controlled trials.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Hee Pyung Park, MD PhD
- Phone Number: 82-2-2072-2466
- Email: hppark@snu.ac.kr
Study Contact Backup
- Name: Eugene Kim, MD
- Phone Number: 82-2-2072-2469
- Email: tomomie@hanmail.net
Study Locations
-
-
-
Seoul, Korea, Republic of, 110-799
- Recruiting
- Seoul National University of Hospital
-
Contact:
- Hee Pyung Park, MD PhD
- Phone Number: 82-2-2072-2466
- Email: hppark@snu.ac.kr
-
Contact:
- Eugene Kim, MD
- Phone Number: 82-2-2072-2469
- Email: tomomie@hanmail.net
-
Principal Investigator:
- Eugene Kim, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patient scheduled for surgery under genearl anesthesia and subclavian vein central catheterization
Exclusion Criteria:
- Patient who does not agree to the study
- Inflammation or infection on catheterization site
- Contralateral diaphragmatic dysfunction
- Anatomic anomalies of subclavian artery or vein/clavicle
- Previous lung surgical history
- Patient who has ventriculoperitoneal shunt or chemoport on same side
- Patient who has pneumo/hemothorax or lung parenchymal disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: GroupC
Group C means Control group which use Seldinger technique for subclavian catheterization.
The aimed vessel(subclavian vein) is punctured with a sharp hollow needle, syringe is detached and guidewire is advanced through the lumen of the needle, and the needle is removed.
After that catheter is passed over the guidewire into the vessel.
|
The aimed vessel(subclavian vein) is punctured with a sharp hollow needle, syringe is detached and guidewire is advanced through the lumen of the needle, and the needle is removed. After that catheter is passed over the guidewire into the vessel.
Other Names:
|
Experimental: Group MS
Group MS means experimental group which use modified Seldinger technique for subclavian catheterization.
The aimed vessel is punctured with the needle that is covered with guiding sheath.
After vessel is punctured, guiding sheath is instatntly slid over the needle into the vessel.
The needle is removed, guidewire is advanced through the sheath, central catheter is placed into the vessel.
|
The aimed vessel is punctured with the needle that is covered with guiding sheath.
After vessel is punctured, guiding sheath is instantly slid over the needle into the vessel.
The needle is removed, guidewire is advanced through the sheath, central catheter is placed into the vessel.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Major complication rate of subclavian catheterization
Time Frame: intraoperative
|
Compare main complication rates of subclavian catheterization including pnumothorax, hemothorax, arterial puncture, malposition of cathter.
|
intraoperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
primary success rate of subclavian catheterization
Time Frame: intraoperative
|
Check the number of attempts of needling, guidewire advance, and catheterization in both groups.
|
intraoperative
|
Total insertion time
Time Frame: From skin puctuation until confim the successful catheterization anticipated within 3min
|
Check the total insertion time from skin puncture to confirm the successful catheterization via venous aspiration though catheter lumen.
|
From skin puctuation until confim the successful catheterization anticipated within 3min
|
Collaborators and Investigators
Investigators
- Study Director: Hee Pyung Park, MD PhD, Professor
- Principal Investigator: Eugene Kim, MD, Clinical Instuctor
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Cardiovascular Diseases
- Vascular Diseases
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Arterial Occlusive Diseases
- Neoplasms
- Neoplasms by Site
- Central Nervous System Neoplasms
- Nervous System Neoplasms
- Carotid Artery Diseases
- Cerebral Arterial Diseases
- Intracranial Arterial Diseases
- Brain Neoplasms
- Moyamoya Disease
- Aneurysm
- Intracranial Aneurysm
Other Study ID Numbers
- Modified seldinger
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Brain Neoplasm
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMetastatic Malignant Neoplasm in the Brain | Recurrent Brain Neoplasm | Central Nervous System Neoplasm | Localized Brain NeoplasmUnited States
-
M.D. Anderson Cancer CenterRecruitingMetastatic Malignant Neoplasm in the Brain | Central Nervous System Neoplasm | Leptomeningeal Neoplasm | Primary Brain NeoplasmUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMetastatic Malignant Neoplasm in the Brain | Malignant Brain Neoplasm | Recurrent Malignant Brain NeoplasmUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); University of HoustonRecruitingBrain Neoplasm | Metastatic Malignant Neoplasm in the Brain | Recurrent Brain NeoplasmUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedMetastatic Malignant Neoplasm in the Brain | Recurrent Brain Neoplasm | Primary Brain NeoplasmUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Brain Neoplasm | Refractory Brain NeoplasmUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMalignant Brain Neoplasm | Recurrent Malignant Brain Neoplasm | Refractory Malignant Brain NeoplasmUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingMetastatic Malignant Solid Neoplasm | Metastatic Malignant Neoplasm in the BrainUnited States
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Metastatic Malignant Neoplasm in the BrainUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedMalignant Childhood Central Nervous System NeoplasmUnited States
Clinical Trials on Seldinger technique
-
Seoul National University HospitalCompletedComplications of Central Venous CatheterizationKorea, Republic of
-
Seoul National University HospitalCompletedCatheterization, Central VenousKorea, Republic of
-
Seoul National University HospitalCompleted
-
University of AlbertaCanadian Association of Emergency PhysiciansCompleted
-
University of ZurichCompletedCatheters, IndwellingSwitzerland
-
Johannes Gutenberg University MainzCompletedCricothyroidotomyGermany
-
University of Lausanne HospitalsWithdrawnVascular Surgical ProceduresSwitzerland
-
University Hospital, Clermont-FerrandCompletedPneumothorax | Hemothorax | Pleural EffusionFrance
-
The University of Hong KongRecruitingPleural Effusion, Malignant | Lung Cancer Stage IV | Chest TubesHong Kong
-
SanofiCompletedCongestive Heart FailureUnited States, Canada, Poland, Romania, Portugal, Sweden, Belgium, Argentina, Denmark, Hungary, Israel, Australia, Chile, South Africa, Greece